1-3 of 3
Michael T. Lotze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort

Amita Patnaik, MD, Ramesh K Ramanathan, MD, Leonard Joseph Appleman, MD, PhD, Anthony W Tolcher, MD, FRCP, James M Mountz, MD, PhD, Muralidhar Beerham, MD, Glen J Weiss, MD, Drew W Rasco, MD, Michael T Lotze, MD, Frederico GS Toledo, MD, Matthew J Oborski, MS, Prabhu Rajagopalan, PhD, Michael Jeffers, PhD, Andrea Kelly, Isabelle Genvresse, MD
Journal: Blood
Blood (2012) 120 (21): 3704.
https://doi.org/10.1182/blood.V120.21.3704.3704
Published: 2012
Journal Articles

Interleukin-17 promotes angiogenesis and tumor growth

Muneo Numasaki, Jun-ichi Fukushi, Mayumi Ono, Satwant K. Narula, Paul J. Zavodny, Toshio Kudo, Paul D. Robbins, Hideaki Tahara, Michael T. Lotze
Journal: Blood
Blood (2003) 101 (7): 2620–2627.
https://doi.org/10.1182/blood-2002-05-1461
Published: 2003
Journal Articles

Interleukin-10 promotes the maintenance of antitumor CD8 + T-cell effector function in situ

Shin-ichiro Fujii, Kanako Shimizu, Takashi Shimizu, Michael T. Lotze
Journal: Blood
Blood (2001) 98 (7): 2143–2151.
https://doi.org/10.1182/blood.V98.7.2143
Published: 2001